Cyclooxygenase enzymes: catalysis and inhibition.
暂无分享,去创建一个
[1] L. Marnett,et al. Control of Prostaglandin Stereochemistry at the 15-Carbon by Cyclooxygenases-1 and -2 , 2002, The Journal of Biological Chemistry.
[2] J. Morrow,et al. Metabolism of Prostaglandin Glycerol Esters and Prostaglandin Ethanolamides in Vitro and in Vivo * , 2001, The Journal of Biological Chemistry.
[3] William L. Smith,et al. Structure of Eicosapentaenoic and Linoleic Acids in the Cyclooxygenase Site of Prostaglandin Endoperoxide H Synthase-1* , 2001, The Journal of Biological Chemistry.
[4] L. Marnett,et al. Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid 2-Arachidonylglycerol* , 2001, The Journal of Biological Chemistry.
[5] R. Kurumbail,et al. A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors. , 2001, The Biochemical journal.
[6] W L Jorgensen,et al. Rationale for the observed COX-2/COX-1 selectivity of celecoxib from Monte Carlo simulations. , 2001, Bioorganic & medicinal chemistry letters.
[7] W. A. van der Donk,et al. Structural characterization of a pentadienyl radical intermediate formed during catalysis by prostaglandin H synthase-2. , 2001, Journal of the American Chemical Society.
[8] P. Loll,et al. Structural analysis of NSAID binding by prostaglandin H2 synthase: time-dependent and time-independent inhibitors elicit identical enzyme conformations. , 2001, Biochemistry.
[9] William L. Smith,et al. Prostaglandin Endoperoxide H Synthase-1 , 2001, The Journal of Biological Chemistry.
[10] M. Malkowski,et al. Mutational and X-ray Crystallographic Analysis of the Interaction of Dihomo-γ-linolenic Acid with Prostaglandin Endoperoxide H Synthases* , 2001, The Journal of Biological Chemistry.
[11] L. Marnett,et al. Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2* , 2000, The Journal of Biological Chemistry.
[12] William L. Jorgensen,et al. Analysis of Binding Affinities for Celecoxib Analogues with COX-1 and COX-2 from Combined Docking and Monte Carlo Simulations and Insight into the COX-2/COX-1 Selectivity , 2000 .
[13] M. Malkowski,et al. The productive conformation of arachidonic acid bound to prostaglandin synthase. , 2000, Science.
[14] L. Marnett,et al. Tyrosine-385 Is Critical for Acetylation of Cyclooxygenase-2 by Aspirin , 2000 .
[15] L. Marnett,et al. Fluorescence quenching analysis of the association and dissociation of a diarylheterocycle to cyclooxygenase-1 and cyclooxygenase-2: dynamic basis of cyclooxygenase-2 selectivity. , 2000, Biochemistry.
[16] Lawrence J. Marnett,et al. Structural insights into the stereochemistry of the cyclooxygenase reaction , 2000, Nature.
[17] W. Smith,et al. Different Catalytically Competent Arrangements of Arachidonic Acid within the Cyclooxygenase Active Site of Prostaglandin Endoperoxide H Synthase-1 Lead to the Formation of Different Oxygenated Products* , 2000, The Journal of Biological Chemistry.
[18] L. Marnett,et al. Spatial Requirements for 15-(R)-Hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic Acid Synthesis within the Cyclooxygenase Active Site of Murine COX-2 , 2000, The Journal of Biological Chemistry.
[19] L. Marnett,et al. Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] L. Marnett,et al. Cyclooxygenase 2 inhibitors: discovery, selectivity and the future. , 1999, Trends in pharmacological sciences.
[21] L. Marnett,et al. The Binding of Arachidonic Acid in the Cyclooxygenase Active Site of Mouse Prostaglandin Endoperoxide Synthase-2 (COX-2) , 1999, The Journal of Biological Chemistry.
[22] L. Marnett,et al. Arachidonic Acid Oxygenation by COX-1 and COX-2 , 1999, The Journal of Biological Chemistry.
[23] J. Koehn,et al. Rapid Kinetics of Tyrosyl Radical Formation and Heme Redox State Changes in Prostaglandin H Synthase-1 and -2* , 1999, The Journal of Biological Chemistry.
[24] R. Kulmacz,et al. Hydroperoxide Dependence and Cooperative Cyclooxygenase Kinetics in Prostaglandin H Synthase-1 and -2* , 1999, The Journal of Biological Chemistry.
[25] A. Mulichak,et al. The Role of Arginine 120 of Human Prostaglandin Endoperoxide H Synthase-2 in the Interaction with Fatty Acid Substrates and Inhibitors* , 1999, The Journal of Biological Chemistry.
[26] J. Gierse,et al. Kinetic basis for selective inhibition of cyclo-oxygenases. , 1999, The Biochemical journal.
[27] R. Kulmacz. Cellular regulation of prostaglandin H synthase catalysis , 1998, FEBS letters.
[28] D. Swinney,et al. Structural Characterization of Arachidonyl Radicals Formed by Prostaglandin H Synthase-2 and Prostaglandin H Synthase-1 Reconstituted with Mangano Protoporphyrin IX* , 1998, The Journal of Biological Chemistry.
[29] C. Bayly,et al. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs. , 1997, Molecular pharmacology.
[30] C. Ramesha,et al. Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2* , 1997, The Journal of Biological Chemistry.
[31] L. Marnett,et al. Mutational Analysis of the Role of the Distal Histidine and Glutamine Residues of Prostaglandin-Endoperoxide Synthase-2 in Peroxidase Catalysis, Hydroperoxide Reduction, and Cyclooxygenase Activation* , 1997, The Journal of Biological Chemistry.
[32] J. Chow,et al. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2 , 1996, Nature Structural Biology.
[33] J. Gierse,et al. A Single Amino Acid Difference between Cyclooxygenase-1 (COX-1) and −2 (COX-2) Reverses the Selectivity of COX-2 Specific Inhibitors* , 1996, The Journal of Biological Chemistry.
[34] P. Loll,et al. Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site. , 1996, Biochemistry.
[35] William L. Smith,et al. Involvement of Arginine 120, Glutamate 524, and Tyrosine 355 in the Binding of Arachidonate and 2-Phenylpropionic Acid Inhibitors to the Cyclooxygenase Active Site of Ovine Prostaglandin Endoperoxide H Synthase-1 (*) , 1996, The Journal of Biological Chemistry.
[36] J. Falgueyret,et al. Arginine 120 of Prostaglandin G/H Synthase-1 Is Required for the Inhibition by Nonsteroidal Anti-inflammatory Drugs Containing a Carboxylic Acid Moiety * , 1995, The Journal of Biological Chemistry.
[37] William L. Smith,et al. Fatty Acid Substrate Specificities of Human Prostaglandin-endoperoxide H Synthase-1 and −2 , 1995, The Journal of Biological Chemistry.
[38] R. Copeland,et al. Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[39] C. Ji,et al. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. , 1994, The Journal of biological chemistry.
[40] K. Seibert,et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Mancini,et al. Mutation of serine‐516 in human prostaglandin G/H synthase‐2 to methionine or aspirin acetylation of this residue stimulates 15‐R‐HETE synthesis , 1994, FEBS letters.
[42] P. Loll,et al. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1 , 1994, Nature.
[43] E. Corey,et al. The Logic of Chemical Synthesis: Multistep Synthesis of Complex Carbogenic Molecules (Nobel Lecture)† , 1991 .
[44] T. Shimokawa,et al. Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysis. , 1990, The Journal of biological chemistry.
[45] Mike Carson,et al. Ribbon models of macromolecules , 1987 .
[46] L. Rome,et al. Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[47] M. Hamberg,et al. On the mechanism of the biosynthesis of prostaglandins E-1 and F-1-alpha. , 1967, The Journal of biological chemistry.
[48] J. Vane,et al. Therapeutic Roles Of Selective Cox-2 Inhibitors , 2001 .
[49] R. Garavito,et al. Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.
[50] J. Falgueyret,et al. Altered sensitivity of aspirin-acetylated prostaglandin G/H synthase-2 to inhibition by nonsteroidal anti-inflammatory drugs. , 1997, Molecular pharmacology.
[51] R. Kurumbail,et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents , 1996, Nature.